Brought to you by 
North American Scientific acquires Theseus Imaging
07 Nov 2000
Executive Summary
North American Scientific Inc. (NASI) (radioisotopic products for disease treatment and diagnosis) has acquired Theseus Imaging Corp. (radiopharmaceuticals) for about $20mm. NASI will issue 346k common shares valued at $9.65mm and assume approximately $10mm in debt including a loan to Theseus to fund trials of its lead product, Apomate.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
North American Scientific acquires Theseus Imaging
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice